| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 151, 151-160, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
M Sanchez-Beato, AI Saez, JC Martinez-Montero, M Sol Mateo, L Sanchez-Verde, R Villuendas, G Troncone and MA Piris
Department of Pathology, Virgen de la Salud Hospital, Toledo, Spain.
Cell cycle progression is regulated by the combined action of cyclins, cyclin-dependent kinases (CDKs), and CDK inhibitors (CDKIs). p27KIP1, which has a high degree of similarity with p21WAF1, is a general CDKI thought to be involved in G1 arrest in response to agents that inhibit cell cycle progression. The aims of this study were 1) to establish the pattern of expression of p27KIP1 protein in nontumor lymphoid tissue, 2) to determine whether p27KIP1 is involved in lymphomagenesis, and 3) to address the possible relationship between p27KIP1 and p21WAF1 expression in reactive and tumor lymphoid tissue. p27KIP1 protein was found to be mainly present in quiescent lymphocytes in reactive lymphoid tissue as well as in peripheral blood lymphocytes, with an inverse expression for p27KIP1 and Ki-67 proteins. The same p27KIP1 expression pattern was observed in lymphomas, independently of histological type; small resting cells were p27KIP1 positive, and large proliferating cells were p27KIP1 negative. Therefore, tumors with a low proliferative index were mostly positive, whereas tumors characterized by a higher growth fraction bad low p27KIP1 protein levels. An unexpected finding was the existence of a group of six cases of high- grade lymphomas (three diffuse large B-cell lymphomas and three Burkitt's lymphomas) with homogeneously strong staining for p27KIP1 protein. All 6 of these cases belong to a group of 28 cases characterized by blockage of the p53 tumor suppressor pathway, as determined by genetic (p53 mutation) or immunophenotypic studies (p53+/p21-). p27KIP1 expression was not seen in any case of aggressive non-Hodgkin's lymphoma with an intact p53 pathway. The results indicate that p27KIP1 is down-regulated in lymphomas with a high proliferative index, although it is highly expressed in high-grade lymphomas with defects in the p53 pathway.
This article has been cited by other articles:
![]() |
S. Quijano, A. Lopez, A. Rasillo, S. Barrena, M. Luz Sanchez, J. Flores, C. Fernandez, J. M. Sayagues, C. S. Osuna, N. Fernandez, et al. Association between the proliferative rate of neoplastic B cells, their maturation stage, and underlying cytogenetic abnormalities in B-cell chronic lymphoproliferative disorders: analysis of a series of 432 patients Blood, May 15, 2008; 111(10): 5130 - 5141. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhang, D. Bergamaschi, B. Jin, and X. Lu Posttranslational modifications of p27kip1 determine its binding specificity to different cyclins and cyclin-dependent kinases in vivo Blood, May 1, 2005; 105(9): 3691 - 3698. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jarviluoma, S. Koopal, S. Rasanen, T. P. Makela, and P. M. Ojala KSHV viral cyclin binds to p27KIP1 in primary effusion lymphomas Blood, November 15, 2004; 104(10): 3349 - 3354. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ghanem, T. H. Van der Kwast, M. K. Sudaryo, R. B. Mathoera, M. M. van den Heuvel, A.-A. M. Al-Doray, R. M. Nijman, and G. J. van Steenbrugge MIB-1 (KI-67) Proliferation Index and Cyclin-Dependent Kinase Inhibitor p27Kip1 Protein Expression in Nephroblastoma Clin. Cancer Res., January 15, 2004; 10(2): 591 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
A A Khan, P D Abel, K S Chaudhary, Z Gulzar, G W H Stamp, and E-N Lalani Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder Mol. Pathol., December 1, 2003; 56(6): 353 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Marafioti, M. Jones, F. Facchetti, T. C. Diss, M.-Q. Du, P. G. Isaacson, M. Pozzobon, S. A. Pileri, A. J. Strickson, S.-Y. Tan, et al. Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology Blood, October 15, 2003; 102(8): 2868 - 2876. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Gelen, G. O. Elpek, N. H. Aksoy, M. Ogus, and N. Keles p27 Labeling Index and Proliferation in Gastrointestinal Stromal Tumors: Correlations with Clinicopathologic Factors and Recurrence Jpn. J. Clin. Oncol., July 1, 2003; 33(7): 346 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Z. Rassidakis, F.-X. Claret, R. Lai, Q. Zhang, A. H. Sarris, T. J. McDonnell, and L. J. Medeiros Expression of p27Kip1 and c-Jun Activation Binding Protein 1 Are Inversely Correlated in Systemic Anaplastic Large Cell Lymphoma Clin. Cancer Res., March 1, 2003; 9(3): 1121 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sanchez-Beato, A. Sanchez-Aguilera, and M. A. Piris Cell cycle deregulation in B-cell lymphomas Blood, February 15, 2003; 101(4): 1220 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gloghini, G. Gaidano, L. M. Larocca, F. Pierconti, A. Cingolani, L. Dal Maso, D. Capello, S. Franceschi, U. Tirelli, M. Libra, et al. Expression of Cyclin-Dependent Kinase Inhibitor p27Kip1 in AIDS-Related Diffuse Large-Cell Lymphomas Is Associated with Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Am. J. Pathol., July 1, 2002; 161(1): 163 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chiarle, Y. Fan, R. Piva, H. Boggino, J. Skolnik, D. Novero, G. Palestro, C. De Wolf-Peeters, M. Chilosi, M. Pagano, et al. S-Phase Kinase-Associated Protein 2 Expression in Non-Hodgkin's Lymphoma Inversely Correlates with p27 Expression and Defines Cells in S Phase Am. J. Pathol., April 1, 2002; 160(4): 1457 - 1466. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakabayashi, I. Sunada, and M. Hara Immunohistochemical Analyses of Cell Cycle-related Proteins, Apoptosis, and Proliferation in Pituitary Adenomas J. Histochem. Cytochem., September 1, 2001; 49(9): 1193 - 1194. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sanchez-Beato, A. I. Saez, I. C. Navas, P. Algara, M. Sol Mateo, R. Villuendas, F. Camacho, A. Sanchez-Aguilera, E. Sanchez, and M. A. Piris Overall Survival in Aggressive B-Cell Lymphomas Is Dependent on the Accumulation of Alterations in p53, p16, and p27 Am. J. Pathol., July 1, 2001; 159(1): 205 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. I. Camacho, J. F. Garcia, L. Sanchez-Verde, A. I. Saez, M. Sanchez-Beato, M. Mollejo, and M. A. Piris Unique Phenotypic Profile of Monocytoid B Cells : Differences in Comparison with the Phenotypic Profile Observed in Marginal Zone B Cells and So-Called Monocytoid B Cell Lymphoma Am. J. Pathol., April 1, 2001; 158(4): 1363 - 1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Schrantz, G. E. Beney, M. T. Auffredou, M. F. Bourgeade, G. Leca, and A. Vazquez The Expression of p18INK4 and p27kip1 Cyclin-Dependent Kinase Inhibitors Is Regulated Differently During Human B Cell Differentiation J. Immunol., October 15, 2000; 165(8): 4346 - 4352. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Carbone, A. Gloghini, D. Bontempo, P. Monini, U. Tirelli, R. Volpe, P. J. Browning, and G. Gaidano Proliferation in HHV-8-Positive Primary Effusion Lymphomas Is Associated with Expression of HHV-8 Cyclin but Independent of p27kip1 Am. J. Pathol., April 1, 2000; 156(4): 1209 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takano, Y. Kato, P. J. van Diest, M. Masuda, H. Mitomi, and I. Okayasu Cyclin D2 Overexpression and Lack of p27 Correlate Positively and Cyclin E Inversely with a Poor Prognosis in Gastric Cancer Cases Am. J. Pathol., February 1, 2000; 156(2): 585 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Shin, H.-S. Kim, J. Park, J.-B. Park, and J.-Y. Lee Mechanism for Inactivation of the KIP Family Cyclin-dependent Kinase Inhibitor Genes in Gastric Cancer Cells Cancer Res., January 1, 2000; 60(2): 262 - 265. [Abstract] [Full Text] |
||||
![]() |
C. C. R. Lee, T. Ichihara, S. Yamamoto, H. Wanibuchi, K. Sugimura, S. Wada, T. Kishimoto, and S. Fukushima Reduced expression of the CDK inhibitor p27KIP1 in rat two-stage bladder carcinogenesis and its association with expression profiles of p21WAF1/Cip1 and p53 Carcinogenesis, September 1, 1999; 20(9): 1697 - 1708. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Cool, J. S. Stewart, P. Werahera, G. J. Miller, R. L. Williams, N. F. Voelkel, and R. M. Tuder Three-Dimensional Reconstruction of Pulmonary Arteries in Plexiform Pulmonary Hypertension Using Cell-Specific Markers : Evidence for a Dynamic and Heterogeneous Process of PulmonaryEndothelial Cell Growth Am. J. Pathol., August 1, 1999; 155(2): 411 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sanchez-Beato, F. I. Camacho, J. C. Martinez-Montero, A. I. Saez, R. Villuendas, L. Sanchez-Verde, J. F. Garcia, and M. A. Piris Anomalous High p27/KIP1 Expression in a Subset of Aggressive B-Cell Lymphomas Is Associated With Cyclin D3 Overexpression. p27/KIP1---Cyclin D3 Colocalization in Tumor Cells Blood, July 15, 1999; 94(2): 765 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Taniguchi, H. Endo, N. Chikatsu, K. Uchimaru, S. Asano, T. Fujita, T. Nakahata, and T. Motokura Expression of p21Cip1/Waf1/Sdi1 and p27Kip1 Cyclin-Dependent Kinase Inhibitors During Human Hematopoiesis Blood, June 15, 1999; 93(12): 4167 - 4178. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fend, L. Quintanilla-Martinez, S. Kumar, M. W. Beaty, L. Blum, L. Sorbara, E. S. Jaffe, and M. Raffeld Composite Low Grade B-Cell Lymphomas with Two Immunophenotypically Distinct Cell Populations Are True Biclonal Lymphomas : A Molecular Analysis Using Laser Capture Microdissection Am. J. Pathol., June 1, 1999; 154(6): 1857 - 1866. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. heng, B. A. Werness, J. S. Babb, and N. J. Meropol Paradoxical Correlations of Cyclin-dependent Kinase Inhibitors p21waf1/cip1 and p27kip1 in Metastatic Colorectal Carcinoma Clin. Cancer Res., May 1, 1999; 5(5): 1057 - 1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Lloyd, L. A. Erickson, L. Jin, E. Kulig, X. Qian, J. C. Cheville, and B. W. Scheithauer p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human Cancers Am. J. Pathol., February 1, 1999; 154(2): 313 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Clurman and P. Porter New insights into the tumor suppression function of P27Kip1 PNAS, December 22, 1998; 95(26): 15158 - 15160. [Full Text] [PDF] |
||||
![]() |
A. M. De Marzo, A. K. Meeker, J. I. Epstein, and D. S. Coffey Prostate Stem Cell Compartments : Expression of the Cell Cycle Inhibitor p27Kip1 inNormal, Hyperplastic, and Neoplastic Cells Am. J. Pathol., September 1, 1998; 153(3): 911 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kawana, J.-i. Tamaru, T. Tanaka, A. Hirai, Y. Saito, M. Kitagawa, A. Mikata, K. Harigaya, and T. Kuriyama Role of p27Kip1 and Cyclin-Dependent Kinase 2 in the Proliferation of Non-Small Cell Lung Cancer Am. J. Pathol., August 1, 1998; 153(2): 505 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Erlanson, C. Portin, B. Linderholm, J. Lindh, G. Roos, and G. Landberg Expression of Cyclin E and the Cyclin-Dependent Kinase Inhibitor p27 in Malignant Lymphomas---Prognostic Implications Blood, August 1, 1998; 92(3): 770 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Quintanilla-Martinez, C. Thieblemont, F. Fend, S. Kumar, M. Pinyol, E. Campo, E. S. Jaffe, and M. Raffeld Mantle Cell Lymphomas Lack Expression of p27kip1, a Cyclin-Dependent Kinase Inhibitor Am. J. Pathol., July 1, 1998; 153(1): 175 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vrhovac, A. Delmer, R. Tang, J.-P. Marie, R. Zittoun, and F. Ajchenbaum-Cymbalista Prognostic Significance of the Cell Cycle Inhibitor p27Kip1 in Chronic B-Cell Lymphocytic Leukemia Blood, June 15, 1998; 91(12): 4694 - 4700. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |